BIOL logo

BIOLASE (BIOL) Cash From Financing

Annual CFF

$17.43 M
+$12.83 M+278.75%

December 31, 2023

Summary

Performance

1-Year Change

+278.75%

3-Year Change

-28.4%

5-Year Change

+55.18%

15-Year Change

-19.35%

BIOL Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$46.75 M
BIOL annual cash flow from financing activities is currently -62.71% below its historical high of $46.75 million

3-Year Low

$4.60 M
BIOL annual cash flow from financing activities is currently +278.75% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
BIOL previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
BIOL next annual earnings announcement has not yet been scheduled

OtherBIOLcash flowmetrics:

Annual CFI

-$1.13 M
BIOL annual cash flow from investing activities is -$1.13 million

Annual CFO

-$14.09 M
BIOL annual cash flow from operations is -$14.09 million

Annual FCF

-$15.40 M
BIOL annual free cash flow is -$15.40 million

Annual CAPEX

$1.31 M
BIOL annual capital expenditures is $1.31 million

Quarterly CFF

$2.49 M
+$2.92 M+681.78%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

-33.71%

3-Year Change

-33.71%

5-Year Change

-33.71%

BIOL Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$39.65 M
BIOL quarterly cash flow from financing activities is currently -93.72% below its historical high of $39.65 million

3-Year Low

-$428.00 K

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
BIOL previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
BIOL next earnings announcement has not yet been scheduled

OtherBIOLcash flowmetrics:

Quarterly CFI

$34.00 K
BIOL quarterly cash flow from investing activities is $34.00 thousand

Quarterly CFO

-$4.47 M
BIOL quarterly cash flow from operations is -$4.47 million

Quarterly FCF

-$4.51 M
BIOL quarterly free cash flow is -$4.51 million

Quarterly CAPEX

$40.00 K
BIOL quarterly capital expenditures is $40.00 thousand

TTM CFF

$8.59 M
-$1.27 M-12.84%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

-47.97%

3-Year Change

-47.97%

5-Year Change

-47.97%

BIOL TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$54.29 M
BIOL TTM cash flow from financing activities is currently -84.17% below its historical high of $54.29 million

3-Year Low

$129.00 K
BIOL TTM cash flow from financing activities is currently +6562.02% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
BIOL previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
BIOL next earnings announcement has not yet been scheduled

OtherBIOLcash flowmetrics:

TTM CFI

$288.00 K
BIOL TTM cash flow from investing activities is $288.00 thousand

TTM CFO

-$13.43 M
BIOL TTM cash flow from operations is -$13.43 million

TTM FCF

-$13.68 M
BIOL TTM free cash flow is -$13.68 million

TTM CAPEX

$252.00 K
BIOL TTM capital expenditures is $252.00 thousand

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

BIOL Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+278.8%-33.7%-48.0%
3 y3 years-28.4%-33.7%-48.0%
5 y5 years+55.2%-33.7%-48.0%

BIOL Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-41.8%-73.6%-70.8%-117.2%-71.3%-98.5%
5 y5-year-41.8%-73.6%-91.7%-117.2%-84.2%-98.5%
alltimeall time-62.7%-130.0%-93.7%-638.2%-84.2%-268.7%

BIOLASE Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
-
$2.49 M(-681.8%)
$8.59 M(-12.8%)
Jun 2024
-
-$428.00 K(-107.6%)
$9.86 M(-32.3%)
Mar 2024
-
$5.65 M(+538.1%)
$14.56 M(-16.5%)
Dec 2023
$17.43 M(+278.8%)
$885.00 K(-76.4%)
$17.43 M(+5.6%)
Sep 2023
-
$3.76 M(-12.2%)
$16.52 M(+31.6%)
Jun 2023
-
$4.28 M(-49.8%)
$12.55 M(-4.4%)
Mar 2023
-
$8.52 M(<-9900.0%)
$13.12 M(+185.0%)
Dec 2022
$4.60 M(-84.6%)
-$32.00 K(-85.0%)
$4.60 M(-2.1%)
Sep 2022
-
-$214.00 K(-104.4%)
$4.70 M(-5.8%)
Jun 2022
-
$4.85 M(>+9900.0%)
$4.99 M(+3769.8%)
Mar 2022
-
$0.00(-100.0%)
$129.00 K(-99.6%)
Dec 2021
$29.95 M(+23.0%)
$68.00 K(-9.3%)
$29.95 M(+0.4%)
Sep 2021
-
$75.00 K(-635.7%)
$29.83 M(-33.9%)
Jun 2021
-
-$14.00 K(-100.0%)
$45.15 M(-16.8%)
Mar 2021
-
$29.82 M(<-9900.0%)
$54.29 M(+123.0%)
Dec 2020
$24.35 M(+127.1%)
-$53.00 K(-100.3%)
$24.35 M(-25.6%)
Sep 2020
-
$15.39 M(+68.6%)
$32.71 M(+89.4%)
Jun 2020
-
$9.13 M(-7901.7%)
$17.27 M(+62.9%)
Mar 2020
-
-$117.00 K(-101.4%)
$10.60 M(-1.1%)
Dec 2019
$10.72 M(-4.6%)
$8.30 M(<-9900.0%)
$10.72 M(-13.7%)
Sep 2019
-
-$50.00 K(-102.0%)
$12.42 M(-11.1%)
Jun 2019
-
$2.46 M(>+9900.0%)
$13.97 M(+45.3%)
Mar 2019
-
$3000.00(-100.0%)
$9.61 M(-14.4%)
Dec 2018
$11.23 M(-48.0%)
$10.00 M(+566.9%)
$11.23 M(-10.7%)
Sep 2018
-
$1.50 M(-179.2%)
$12.58 M(+14.6%)
Jun 2018
-
-$1.89 M(-216.6%)
$10.97 M(-52.9%)
Mar 2018
-
$1.62 M(-85.7%)
$23.29 M(+7.7%)
Dec 2017
$21.62 M(+131.2%)
$11.35 M(<-9900.0%)
$21.62 M(+111.5%)
Sep 2017
-
-$104.00 K(-101.0%)
$10.22 M(-48.4%)
Jun 2017
-
$10.42 M(<-9900.0%)
$19.81 M(+111.9%)
Mar 2017
-
-$43.00 K(-12.2%)
$9.35 M(0.0%)
Dec 2016
$9.35 M(-9004.8%)
-$49.00 K(-100.5%)
$9.35 M(+0.4%)
Sep 2016
-
$9.48 M(<-9900.0%)
$9.32 M(-4926.9%)
Jun 2016
-
-$43.00 K(0.0%)
-$193.00 K(+28.7%)
Mar 2016
-
-$43.00 K(-48.2%)
-$150.00 K(+42.9%)
Dec 2015
-$105.00 K(-100.2%)
-$83.00 K(+245.8%)
-$105.00 K(-100.3%)
Sep 2015
-
-$24.00 K(<-9900.0%)
$34.80 M(-19.2%)
Jun 2015
-
$0.00(-100.0%)
$43.08 M(-0.9%)
Mar 2015
-
$2000.00(-100.0%)
$43.48 M(-7.0%)
Dec 2014
$46.75 M(+428.5%)
$34.82 M(+321.6%)
$46.75 M(+302.4%)
Sep 2014
-
$8.26 M(+1969.9%)
$11.62 M(+55.5%)
Jun 2014
-
$399.00 K(-87.8%)
$7.47 M(-28.3%)
Mar 2014
-
$3.28 M(-1140.0%)
$10.42 M(+17.8%)
Dec 2013
$8.85 M(+467.5%)
-$315.00 K(-107.7%)
$8.85 M(+2.8%)
Sep 2013
-
$4.11 M(+22.6%)
$8.61 M(+89.5%)
Jun 2013
-
$3.35 M(+97.2%)
$4.54 M(+52.3%)
Mar 2013
-
$1.70 M(-408.0%)
$2.98 M(+91.3%)
Dec 2012
$1.56 M(-89.9%)
-$552.00 K(-1383.7%)
$1.56 M(-16.4%)
Sep 2012
-
$43.00 K(-97.6%)
$1.86 M(-0.1%)
Jun 2012
-
$1.79 M(+546.6%)
$1.87 M(-82.6%)
Mar 2012
-
$277.00 K(-212.6%)
$10.72 M(-30.3%)
Dec 2011
$15.39 M(+446.8%)
-$246.00 K(-659.1%)
$15.39 M(+0.0%)
Sep 2011
-
$44.00 K(-99.6%)
$15.38 M(-0.4%)
Jun 2011
-
$10.65 M(+115.4%)
$15.45 M(+99.3%)
Mar 2011
-
$4.94 M(-2085.1%)
$7.75 M(+175.4%)
Dec 2010
$2.81 M(-153.8%)
-$249.00 K(-334.9%)
$2.81 M(-9.1%)
Sep 2010
-
$106.00 K(-96.4%)
$3.10 M(-1.1%)
Jun 2010
-
$2.95 M(>+9900.0%)
$3.13 M(+1629.3%)
Mar 2010
-
$8000.00(-76.5%)
$181.00 K(-103.5%)
Dec 2009
-$5.23 M
$34.00 K(-75.5%)
-$5.23 M(+22.4%)
Sep 2009
-
$139.00 K(>+9900.0%)
-$4.27 M(<-9900.0%)
Jun 2009
-
$0.00(-100.0%)
$9000.00(-100.5%)
DateAnnualQuarterlyTTM
Mar 2009
-
-$5.40 M(-644.2%)
-$1.75 M(-173.6%)
Dec 2008
$2.38 M(-44.3%)
$993.00 K(-77.5%)
$2.38 M(-54.1%)
Sep 2008
-
$4.42 M(-350.6%)
$5.19 M(+555.8%)
Jun 2008
-
-$1.76 M(+39.4%)
$792.00 K(-71.9%)
Mar 2008
-
-$1.26 M(-133.3%)
$2.82 M(-34.2%)
Dec 2007
$4.28 M(-323.6%)
$3.80 M(>+9900.0%)
$4.28 M(+125.1%)
Sep 2007
-
$18.00 K(-93.1%)
$1.90 M(-221.0%)
Jun 2007
-
$261.00 K(+32.5%)
-$1.57 M(-18.2%)
Mar 2007
-
$197.00 K(-86.2%)
-$1.92 M(+0.3%)
Dec 2006
-$1.91 M(-134.5%)
$1.43 M(-141.3%)
-$1.91 M(-42.4%)
Sep 2006
-
-$3.45 M(+3825.0%)
-$3.32 M(-210.1%)
Jun 2006
-
-$88.00 K(-143.3%)
$3.02 M(-24.0%)
Mar 2006
-
$203.00 K(+1027.8%)
$3.96 M(-28.6%)
Dec 2005
$5.55 M(-76.2%)
$18.00 K(-99.4%)
$5.55 M(+132.0%)
Sep 2005
-
$2.88 M(+234.3%)
$2.39 M(-117.2%)
Jun 2005
-
$862.00 K(-51.9%)
-$13.89 M(-4.2%)
Mar 2005
-
$1.79 M(-157.0%)
-$14.50 M(-162.1%)
Dec 2004
$23.35 M(+678.7%)
-$3.14 M(-76.5%)
$23.35 M(-10.1%)
Sep 2004
-
-$13.40 M(-5460.0%)
$25.98 M(-34.2%)
Jun 2004
-
$250.00 K(-99.4%)
$39.49 M(-3.7%)
Mar 2004
-
$39.65 M(-7813.0%)
$41.00 M(+1267.3%)
Dec 2003
$3.00 M(+151.4%)
-$514.00 K(-558.9%)
$3.00 M(-24.0%)
Sep 2003
-
$112.00 K(-93.6%)
$3.94 M(+2.7%)
Jun 2003
-
$1.76 M(+7.4%)
$3.84 M(+82.1%)
Mar 2003
-
$1.64 M(+280.5%)
$2.11 M(+76.9%)
Dec 2002
$1.19 M(-438.0%)
$431.00 K(+4210.0%)
$1.19 M(-529.1%)
Sep 2002
-
$10.00 K(-65.5%)
-$278.00 K(+1.2%)
Jun 2002
-
$29.00 K(-96.0%)
-$274.70 K(-308.1%)
Mar 2002
-
$723.00 K(-169.5%)
$132.00 K(-137.4%)
Dec 2001
-$353.00 K(-106.2%)
-$1.04 M(-7919.5%)
-$353.00 K(-146.8%)
Sep 2001
-
$13.30 K(-96.9%)
$754.80 K(-4.8%)
Jun 2001
-
$435.70 K(+83.1%)
$793.00 K(-48.8%)
Mar 2001
-
$238.00 K(+251.0%)
$1.55 M(-72.7%)
Dec 2000
$5.67 M(+129.5%)
$67.80 K(+31.7%)
$5.67 M(+1.8%)
Sep 2000
-
$51.50 K(-95.7%)
$5.57 M(-0.9%)
Jun 2000
-
$1.19 M(-72.7%)
$5.62 M(+43.1%)
Mar 2000
-
$4.36 M(<-9900.0%)
$3.93 M(+59.0%)
Dec 1999
$2.47 M(-51.6%)
-$29.80 K(-129.8%)
$2.47 M(-14.8%)
Sep 1999
-
$100.00 K(-120.0%)
$2.90 M(-3.3%)
Jun 1999
-
-$500.00 K(-117.2%)
$3.00 M(-57.1%)
Mar 1999
-
$2.90 M(+625.0%)
$7.00 M(+37.3%)
Dec 1998
$5.10 M(+325.0%)
$400.00 K(+100.0%)
$5.10 M(0.0%)
Sep 1998
-
$200.00 K(-94.3%)
$5.10 M(+4.1%)
Jun 1998
-
$3.50 M(+250.0%)
$4.90 M(+250.0%)
Mar 1998
-
$1.00 M(+150.0%)
$1.40 M(+16.7%)
Dec 1997
$1.20 M(-73.3%)
$400.00 K(>+9900.0%)
$1.20 M(-76.9%)
Sep 1997
-
$0.00(0.0%)
$5.20 M(0.0%)
Jun 1997
-
$0.00(-100.0%)
$5.20 M(-1.9%)
Mar 1997
-
$800.00 K(-81.8%)
$5.30 M(+17.8%)
Dec 1996
$4.50 M(+114.3%)
$4.40 M(>+9900.0%)
$4.50 M(+4400.0%)
Sep 1996
-
$0.00(-100.0%)
$100.00 K(-92.3%)
Jun 1996
-
$100.00 K(>+9900.0%)
$1.30 M(-38.1%)
Mar 1996
-
$0.00(0.0%)
$2.10 M(0.0%)
Dec 1995
$2.10 M(+10.5%)
$0.00(-100.0%)
$2.10 M(0.0%)
Sep 1995
-
$1.20 M(+33.3%)
$2.10 M(+133.3%)
Jun 1995
-
$900.00 K(>+9900.0%)
$900.00 K(>+9900.0%)
Mar 1995
-
$0.00(-100.0%)
$0.00(-100.0%)
Dec 1994
$1.90 M(-71.2%)
-
-
Dec 1993
$6.60 M(+1.5%)
$2.80 M(+64.7%)
$6.60 M(+73.7%)
Sep 1993
-
$1.70 M(+13.3%)
$3.80 M(+81.0%)
Jun 1993
-
$1.50 M(+150.0%)
$2.10 M(+250.0%)
Mar 1993
-
$600.00 K
$600.00 K
Dec 1992
$6.50 M
-
-

FAQ

  • What is BIOLASE annual cash flow from financing activities?
  • What is the all time high annual CFF for BIOLASE?
  • What is BIOLASE annual CFF year-on-year change?
  • What is BIOLASE quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for BIOLASE?
  • What is BIOLASE quarterly CFF year-on-year change?
  • What is BIOLASE TTM cash flow from financing activities?
  • What is the all time high TTM CFF for BIOLASE?
  • What is BIOLASE TTM CFF year-on-year change?

What is BIOLASE annual cash flow from financing activities?

The current annual CFF of BIOL is $17.43 M

What is the all time high annual CFF for BIOLASE?

BIOLASE all-time high annual cash flow from financing activities is $46.75 M

What is BIOLASE annual CFF year-on-year change?

Over the past year, BIOL annual cash flow from financing activities has changed by +$12.83 M (+278.75%)

What is BIOLASE quarterly cash flow from financing activities?

The current quarterly CFF of BIOL is $2.49 M

What is the all time high quarterly CFF for BIOLASE?

BIOLASE all-time high quarterly cash flow from financing activities is $39.65 M

What is BIOLASE quarterly CFF year-on-year change?

Over the past year, BIOL quarterly cash flow from financing activities has changed by -$1.27 M (-33.71%)

What is BIOLASE TTM cash flow from financing activities?

The current TTM CFF of BIOL is $8.59 M

What is the all time high TTM CFF for BIOLASE?

BIOLASE all-time high TTM cash flow from financing activities is $54.29 M

What is BIOLASE TTM CFF year-on-year change?

Over the past year, BIOL TTM cash flow from financing activities has changed by -$7.92 M (-47.97%)